Monitor for future disclosures of financial terms or initial adoption metrics from the Evoke clinician network. Without deal economics, the partnership's revenue contribution is unquantifiable.
Price Chart
Executive Summary
Firefly Neuroscience announces a partnership with NeuroSigma to introduce the second-generation Monarch eTNS System to Firefly's Evoke clinician network. The deal expands Firefly's therapeutic offerings but lacks disclosed financial terms, making the material impact uncertain.
Key Facts
- Partnership with NeuroSigma to introduce second-generation Monarch eTNS System
- System to be offered to Firefly's nationwide network of Evoke clinicians
- No financial terms, upfront payments, milestones, or revenue projections disclosed
Financial Impact
Undisclosed — no deal value, revenue share, or financial terms provided
Risk Factors
- No disclosed financial terms — partnership may be non-material or exploratory
- Commercial adoption by Evoke clinicians is uncertain without pricing or reimbursement details
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3369065 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 25, 2026 4w ago | Press Release | $2.01 $0.9196 | ▼ −54.25% | ▼ −52.77% | $0.9900 (−50.75%) |
Sep 17, 2026 5w ago | Press Release | $1.28 $1.10 | ▼ −14.06% | ▼ −15.52% | $0.9900 (−22.66%) |
Jul 1, 2026 16w ago | EFFECT | $1.29 $1.07 | ▲ +17.05% | ▲ +14.87% | $0.9900 (+23.26%) |
Jun 26, 2026 17w ago | 8-K | $1.23 $1.11 | ▲ +9.76% | ▲ +9.48% | $0.9900 (+19.51%) |
Jun 23, 2026 17w ago | S-3/A | $1.19 $1.13 | ▲ +5.04% | ▲ +6.97% | $0.9900 (+16.81%) |
Jun 22, 2026 18w ago | 8-K | $1.31 $1.12 | ▼ −14.50% | ▼ −15.66% | $0.9900 (−24.43%) |
May 12, 2026 23w ago | 8-K | $1.80 $1.61 | ▲ +10.56% | ▲ +9.94% | $0.9900 (+45.00%) |
Apr 22, 2026 26w ago | 8-K | $2.06 $1.68 | ▼ −18.45% | ▼ −23.08% | $0.9900 (−51.94%) |
Mar 26, 2026 30w ago | Press Release | $3.02 $2.29 | ▼ −24.17% | ▼ −34.84% | $0.9900 (−67.22%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers